A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2006
12/28/2006	CA2612516A1 Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma
12/28/2006	CA2612410A1 Lkktet (seq id no: 1) and/or lkktnt (seq id no: 2) peptide compositions wich are lyophilized or in a form capable of being lyophilized
12/28/2006	CA2612405A1 Lkktet and/or lkktnt compositions and methods for treating or preventing tissue deterioration, injury or damage
12/28/2006	CA2612355A1 Antibody complexes
12/28/2006	CA2612302A1 Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis
12/28/2006	CA2611936A1 Botulinum toxin and the treatment of primary disorders of mood and affect
12/28/2006	CA2611816A1 Methods of purifying fc region containing proteins
12/28/2006	CA2611815A1 Methods of purifying anti a beta antibodies
12/28/2006	CA2611519A1 Ilt3 binding molecules and uses therefor
12/28/2006	CA2610839A1 Self-buffering protein formulations
12/28/2006	CA2608278A1 Immunogenic compositions for chlamydia trachomatis
12/28/2006	CA2606084A1 Improved method of treating degenerative spinal disorders
12/28/2006	CA2586765A1 Purposeful movement of human migratory cells away from an agent source
12/27/2006	EP1736547A1 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation
12/27/2006	EP1736539A1 Attenuated SARS-CoV vaccines
12/27/2006	EP1736484A1 An gene enginf; ering recombinant anti-cea, anti-cd3 and anti-cd28 single-chain tri-specific antibody
12/27/2006	EP1736172A1 Method of utilizing organic cation transporter oct3-related molecule for treating mental diseases such as depression, anxiety neurosis, drug addiction and the like
12/27/2006	EP1736170A2 Agent for treating allergic or hypersensitivity condition
12/27/2006	EP1736163A1 CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
12/27/2006	EP1736162A1 Remedy for prion disease and method of producing the same
12/27/2006	EP1736152A2 Physiologically stable compositions of butyric acid as well as butyric acid salts and derivatives for treating wounds
12/27/2006	EP1735469A2 Apparatus and method for transdermal delivery of multiple vaccines
12/27/2006	EP1735463A2 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators in non-small cell lung cancer
12/27/2006	EP1735445A2 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
12/27/2006	EP1735432A1 Cancerous disease modifying antibodies
12/27/2006	EP1735348A1 Human anti-epidermal growth factor receptor antibody
12/27/2006	EP1735347A2 Specific binding members against synaptophysin
12/27/2006	EP1735338A2 Anthrax antigens and methods of use
12/27/2006	EP1735027A2 Stabilized biodegradable neurotoxin implants
12/27/2006	EP1735011A2 Method of modulating vascularization
12/27/2006	EP1735010A2 Methods, compositions, and preparations for delivery of immune response modifiers
12/27/2006	EP1735000A2 Method for augmenting b cell depletion
12/27/2006	EP1734998A2 Compositions and methods comprising an egfl7 antagonist for modulating vascular development
12/27/2006	EP1734997A2 Steroid sparing agents and methods of using same
12/27/2006	EP1734996A2 Methods and compositions for treating and preventing disease associated with alpha v beta 5 integrin
12/27/2006	EP1734995A1 Monoclonal antibodies to hepatocyte growth factor
12/27/2006	EP1734994A1 Site-specific chemical modification of hiv gp41-derived peptides
12/27/2006	EP1734993A2 Apparatus and method for transdermal delivery of influenza vaccine
12/27/2006	EP1734992A2 Improved inactivated fcv vaccines
12/27/2006	EP1734984A2 Compositions and methods for topical diagnostic and therapeutic transport
12/27/2006	EP1507863B1 Plasmid stabilisation in vivo
12/27/2006	EP1418180B1 Chimeric chains that code for proteins that induce effects directed against viruses
12/27/2006	EP1373500B1 Gene involved in v(d)j recombination and/or dna repair
12/27/2006	EP1332372B1 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression
12/27/2006	EP1297147B1 Compositions for the diagnosis and treatment of herpes simplex virus infection
12/27/2006	EP1280912B1 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same
12/27/2006	EP1242401B1 Cytotoxic agents comprising taxanes and their therapeutic use
12/27/2006	EP1225870B1 Composition and method of cancer antigen immunotherapy
12/27/2006	EP1183367B1 Cytotoxic t-cell epitope of the papillomavirus l1-protein and use thereof in diagnostics and therapy
12/27/2006	EP1183362B1 Il-1 eta dna and polypeptides
12/27/2006	EP1117437B1 Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke
12/27/2006	EP1105505B1 Compound and method for the prevention and/or the treatment of allergy
12/27/2006	EP1084252B1 Nucleic acid vaccines for prevention of flavivirus infection
12/27/2006	EP1034273B1 Histamine and serotonin binding molecules
12/27/2006	EP1028742B1 Apo b, annexin v and tubulin : medical, diagnostic and purification uses for hcv
12/27/2006	EP1021547B1 Papilloma virus capsomere vaccine formulations and methods of use
12/27/2006	EP1003875B1 Group a streptococcal vaccines
12/27/2006	EP0973804B1 Anti-vegf antibodies
12/27/2006	EP0918458B1 Antimicrobial treatment for herpes simplex virus and other infectious diseases
12/27/2006	CN1886509A HIV pharmaccines
12/27/2006	CN1886425A Methods, kits, and compositions for the development and use of monoclonal antibodies specific to antigens traditionally of low immunogenicity
12/27/2006	CN1886424A Anti-IGF-I receptor antibody
12/27/2006	CN1886158A Pharmaceutical preparation comprising an antibody against the EGF receptor
12/27/2006	CN1886156A Immunotherapy method
12/27/2006	CN1886155A Isolated mammalian membrane protein genes and related reagents
12/27/2006	CN1886148A Selective inhibition of NF-kB activation by peptides designed to disrupt NEMO oligomerization
12/27/2006	CN1886128A Compositions and methods for treating burns
12/27/2006	CN1886118A Solid forms of anti-EGFR-antibodies.
12/27/2006	CN1884552A Recombinant Ag85B-Rv3425 bacillus Calmette-Guerin vaccine
12/27/2006	CN1884535A Anti human CD19 mouse immune globulin variable zone gene and uses
12/27/2006	CN1884505A Tumour related protein kinase RX17 and its uses
12/27/2006	CN1884499A Recombinant pig japanese b encephalitis-aujeszkys disease geneticly engineered strain vaccine and its uses
12/27/2006	CN1884498A Recombinant fowl influenza virus strain, its preparation method and the vaccine obtained therefrom
12/27/2006	CN1884497A Reovirus vaccine and its preparing method
12/27/2006	CN1884303A SARS-CoV virus structural protein infusion protein and its high yield expression and purification and uses
12/27/2006	CN1884302A Staphylococcus aureus fusion protein of fibronectin and bindin, its preparation method and uses
12/27/2006	CN1884301A Targeted function superantigen and its preparation method and use
12/27/2006	CN1884300A Targeted function anti-liver cancer superantigen and its preparation method and use
12/27/2006	CN1884299A Staphylococcus aureus surface protein fusion protein, its preparation method and uses
12/27/2006	CN1883705A Application of cysteamine and derivative thereof in preparation of medicament for improving bird flu antibody potency
12/27/2006	CN1883704A Hepatitis A-hepatitis E combined vaccine and preparation method thereof
12/27/2006	CN1883454A Liposome administration system with tumor necrosis targeted antibody for preposition and application thereof
12/27/2006	CN1292071C Attenuated vaccinia virus Tiantan strain vector and its preparation and application
12/27/2006	CN1292069C HIV-1 virus tat-protein mutants
12/27/2006	CN1291758C Coupling agent of CB and specific immune globulin IgG and medical use thereof
12/27/2006	CN1291757C Remedy for inflammatory bowel diseases
12/27/2006	CN1291756C Blood cell production via activation of hemeglobin scavenger receptor
12/27/2006	CN1291755C Pharmaceutical compositions capable of enhancing the immunogenicity of poorly immunogenic antigens
12/26/2006	US7155345 System for regulating the handling of milk during the milking process and a method for regulating said milking process
12/26/2006	US7153952 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
12/26/2006	US7153947 Ixodes salivary anticomplement protein
12/26/2006	US7153945 Peptide, novel adsorbent, adsorption unit and adsorption method
12/26/2006	US7153942 Polypeptide for use in the treatment of inflammation, rheumatoid arritis, psoriasis, and diabetic retinopathy
12/26/2006	US7153940 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
12/26/2006	US7153936 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity
12/26/2006	US7153827 Produced by recombinant techniques; stimulating angiogenesis for wound healing and for vascular tissue repair
12/26/2006	US7153677 Isolated, recombinantly produced, enzymatically active hyaluronan synthase; a single protein that is a dual-action catalyst that utilizes UDP-GlcA and UDP-GlcNAc to synthesize hyaluronic acid
12/26/2006	US7153669 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
12/26/2006	US7153665 Using retroviral expression vector comprising immunoglobulin E and regulatory sequences to transfom cells and identify regulator of immunoglobulin E biosynthesis
12/26/2006	US7153662 Inflammation-specific peptides and the uses thereof

1 ... 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 ... 1823